FollowTheFilings

Managers Activity Compare Newest

Investment

HALOZYME THERAPEUTICS INC

Historical 13F holders

CUSIP: 40637HAD1
Type: Debt
Class: NOTE 0.250% 3/0

Period	13F filings
2026 Q1	2
2025 Q4	2
2025 Q3	2
2025 Q2	4
2025 Q1	1
2024 Q4	1

FollowTheFilings · Institutional 13F data room

All managers Activity Compare Newest filings X

Data is sourced from SEC EDGAR as filed. The SEC does not guarantee accuracy or completeness. Holdings exclude shorts and many derivatives; values are as of the report date.